# Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Canonical URL: https://biopharmsignal.com/news/NAUT/nautilus-biotechnology-to-announce-fourth-quarter-and-full-year-2025-financial-r-1b8238b0
Ticker: NAUT
Company: Nautilus Biotechnology
Source: Nautilus Biotechnology
Published: 2026-02-05 13:00 EST
## Summary

Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein...

## Article Body
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform, today announced it will report financial results for the fourth quarter and full year 2025 before market open on Thursday, February 26, 2026.

The company’s management will webcast a corresponding conference call beginning at 5:30 a.m. Pacific Time / 8:30 a.m. Eastern Time to discuss its results, business developments, and outlook. Live audio of the webcast will be available on the “Investors” section of the company website at: www.nautilus.bio .

About Nautilus Biotechnology, Inc. With its corporate headquarters in Seattle, Washington and its research and development headquarters in San Carlos, California, Nautilus is a development stage life sciences company working to create a platform technology for quantifying and unlocking the complexity of the proteome. Nautilus’ mission is to transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. To learn more about Nautilus, visit www.nautilus.bio .

Media Contact press@nautilus.bio

Investor Contact investorrelations@nautilus.bio
## Recent Company News
- 2026-07-28 12:00 EST — [Nautilus Biotechnology Reports Second Quarter 2026 Financial Results](https://biopharmsignal.com/news/NAUT/nautilus-biotechnology-reports-second-quarter-2026-financial-results-6bb2d24b) — Source: Nautilus Biotechnology
- 2026-07-08 12:00 EST — [Nautilus Biotechnology to Announce Second Quarter 2026  Financial Results on July 28, 2026](https://biopharmsignal.com/news/NAUT/nautilus-biotechnology-to-announce-second-quarter-2026-financial-results-on-july-ffc9b6aa) — Source: Nautilus Biotechnology
- 2026-04-28 12:00 EST — [Nautilus Biotechnology Reports First Quarter 2026 Financial Results](https://biopharmsignal.com/news/NAUT/nautilus-biotechnology-reports-first-quarter-2026-financial-results-be1ada7a) — Source: Nautilus Biotechnology
- 2026-04-09 12:00 EST — [Nautilus Biotechnology to Announce First Quarter 2026 Financial Results on April 28, 2026](https://biopharmsignal.com/news/NAUT/nautilus-biotechnology-to-announce-first-quarter-2026-financial-results-on-april-a00320ac) — Source: Nautilus Biotechnology
- 2026-03-24 12:00 EST — [Nautilus Biotechnology to Participate in the Investor Summit Group Virtual Conference](https://biopharmsignal.com/news/NAUT/nautilus-biotechnology-to-participate-in-the-investor-summit-group-virtual-confe-1d3fd49b) — Source: Nautilus Biotechnology
## Related News
- 2026-07-29 14:05 EST — CAPR — [The Lancet Publishes HOPE-3 Data for Capricor Therapeutics’ Deramiocel in Duchenne Muscular Dystrophy](https://biopharmsignal.com/news/CAPR/the-lancet-publishes-hope-3-data-for-capricor-therapeutics-deramiocel-in-duchenn-9e6e6bd9)
- 2026-07-29 13:00 EST — ENLV — [Enlivex Management to Host Webinar to Discuss Capital Strategy, Rain Protocol Treasury Strategy, and Recent Clinical Milestones](https://biopharmsignal.com/news/ENLV/enlivex-management-to-host-webinar-to-discuss-capital-strategy-rain-protocol-tre-5921a627)
- 2026-07-29 12:30 EST — PRGO — [Perrigo to Present at the Canaccord 46th Annual Growth Conference](https://biopharmsignal.com/news/PRGO/perrigo-to-present-at-the-canaccord-46th-annual-growth-conference-40431922)
- 2026-07-29 12:30 EST — LIXT — [NOMAD Announces Operational Deployment of Two Mobile Battery Systems by DSO Electric Cooperative](https://biopharmsignal.com/news/LIXT/nomad-announces-operational-deployment-of-two-mobile-battery-systems-by-dso-elec-7fc12a2c)
- 2026-07-29 12:30 EST — RNXT — [RenovoRx to Host Second Quarter 2026 Financial Results and Business Highlights Conference Call on August 12th at 4:30 p.m. ET](https://biopharmsignal.com/news/RNXT/renovorx-to-host-second-quarter-2026-financial-results-and-business-highlights-c-8bed10ec)